Mr. Mehdi Narimani, Vice President of Human Resources at Golrang Pharmaceutical Group, has emphasized the unwavering commitment of the holding’s subsidiaries to maintain uninterrupted production and healthcare services despite the current national challenges.
According to the Golrang Pharmaceutical Group’s Public Relations Department, Mr. Narimani compared the current conditions to the peak of the COVID-19 pandemic in Iran, highlighting the group’s steadfast role in frontline service during crises.
“Just like during the pandemic, we continue to operate with a deep sense of responsibility to ensure public health and uninterrupted medicine supply across the country,” he stated.
Commitment to Health and Resilience in the Face of Adversity
Golrang Pharmaceutical Holding, as a key player in Iran’s pharmaceutical industry, has reiterated its mission of safeguarding community health, particularly in sensitive and high-pressure times.
Mr. Narimani expressed appreciation for the dedication of staff across all sites and subsidiaries. “Our colleagues in API production and finished dosage manufacturing remain committed, standing firm despite the challenges—just as they did during the pandemic—so that the drug supply chain continues without disruption.”
He also noted the role of Salamat Pakhsh Hasti, the group’s pharmaceutical distribution arm, which operates 22 active branches nationwide to maintain the seamless flow of medicines and health products from production to end-user.
Employee Safety and Operational Flexibility
Addressing workforce well-being, Mr. Narimani noted that while production operations continue with full strength, flexible work arrangements have been implemented where possible, especially in administrative and headquarters functions.
“Our top priority is the physical and psychological security and well-being of our colleagues,” he added, noting that decisions are tailored based on each company’s context.
In closing, Mr. Narimani expressed confidence that with unity and shared purpose among stakeholders, the group will successfully navigate these difficult times and continue to serve the nation’s healthcare needs.
